Company intelligence / Profile preview

Erbagil

Guardia Sanframondi, Benevento, Italy
Ownership
Private
Development stage
Other
01

Overview

Erbagil is an Italian pharmaceutical and biotechnology company specializing in the research, development, and production of innovative medical devices, cosmetics, and food supplements. The company's core technology is Ozoile, a patented pool of stable ozonides produced through the ozonization of organic extra virgin olive oil, which acts as a biological inducer for tissue repair and anti-inflammatory responses. Erbagil operates a complete supply chain from organic cultivation to final manufacturing, focusing on therapeutic areas such as dermatology, gynecology, and proctology. Their product portfolio includes brands like Rigenera, Vulvovagi, and Procten, which are marketed globally for various inflammatory and infectious conditions.

Therapeutic areas
Women's HealthDermatologyGastroenterology
Modalities
Small moleculeDevice
Industry
Biotech
02

Drug pipeline

1 asset

acidified aliphatic ester

Unknown

Beyond the preview

Go deeper on Erbagil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erbagil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call